315 related articles for article (PubMed ID: 28192149)
1. Serum uric acid and anti-N-methyl-d-aspartate receptor encephalitis.
Shu Y; Wang Y; Lu T; Li R; Sun X; Li J; Chang Y; Hu X; Lu Z; Qiu W
Neurochem Int; 2017 Sep; 108():34-39. PubMed ID: 28192149
[TBL] [Abstract][Full Text] [Related]
2. Lipid Metabolism in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Shu Y; Qin B; Xu Y; Sun X; Chen Z; Wang J; Peng L; Qiu W; Lu Z; Wu A
Neuroimmunomodulation; 2017; 24(4-5):256-263. PubMed ID: 29393234
[TBL] [Abstract][Full Text] [Related]
3. Serum complement levels in anti-N-methyl-d-aspartate receptor encephalitis.
Shu Y; Chen C; Chen Y; Xu Y; Chang Y; Li R; Sun X; Peng L; Lu Z; Qiu W
Eur J Neurol; 2018 Jan; 25(1):178-184. PubMed ID: 29053906
[TBL] [Abstract][Full Text] [Related]
4. Serum cystatin C and anti-N-methyl-D-aspartate receptor encephalitis.
Shu Y; Chang Y; Wu H; Li J; Cao B; Sun X; Wang J; Peng L; Hu X; Yu X; Qiu W
Acta Neurol Scand; 2018 May; 137(5):515-522. PubMed ID: 29315460
[TBL] [Abstract][Full Text] [Related]
5. Association of serum Gasdermin D with anti-N-methyl-D-aspartate receptor encephalitis.
Ma X; Chen C; Lu Y; Fang L; Cao B; Hu X; Qiu W; Shu Y
J Neurochem; 2021 Dec; 159(5):923-930. PubMed ID: 34418095
[TBL] [Abstract][Full Text] [Related]
6. Serum Bilirubin and Albumin in Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Shu Y; Xu Y; Chen C; Li J; Li R; Wu H; Hu X; Lu Z; Yu X; Qiu W
Neuroimmunomodulation; 2018; 25(4):206-214. PubMed ID: 30497071
[TBL] [Abstract][Full Text] [Related]
7. Thyroid Function and Autoimmune Indications in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Ma X; Yin Q; Zeng Z; Wang C; Yang Y; Guo S
Neuroimmunomodulation; 2018; 25(2):110-117. PubMed ID: 30157483
[TBL] [Abstract][Full Text] [Related]
8. Low serum vitamin D levels and anti-N-methyl-d-aspartate receptor encephalitis: A case-control study.
Shu Y; Su Q; Liao S; Lu T; Li R; Sun X; Qiu W; Yang Y; Hu X; Lu Z
Neurochem Int; 2017 Jan; 102():89-94. PubMed ID: 27836631
[TBL] [Abstract][Full Text] [Related]
9. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis.
Wang R; Guan HZ; Ren HT; Wang W; Hong Z; Zhou D
Seizure; 2015 Jul; 29():137-42. PubMed ID: 26076857
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid uric acid levels associated with disease severity in patients with anti-N-methyl-d-aspartate receptor encephalitis.
Cao B; Li Q; Xiong L; Ruan H; Lu Y; Peng F; Li H; Huang Y; Luo M; Shu Y
J Neuroimmunol; 2023 Nov; 384():578221. PubMed ID: 37864934
[TBL] [Abstract][Full Text] [Related]
11. Simple and effective serum biomarkers potential for predicting status epilepticus in anti-N-methyl-D-aspartate receptor encephalitis.
Liu Y; Ma L; Ma X; Ma X; Li J; Li D; Lin X; Su Z; Chen X
BMC Neurol; 2022 Jan; 22(1):27. PubMed ID: 35031011
[TBL] [Abstract][Full Text] [Related]
12. Elevated CHI3L1 and OPN levels in patients with anti-N-methyl-d-aspartate receptor encephalitis.
Zhao J; Wang C; Zhang Y; Sun R; Wang H; Li G; Zhang J
J Neuroimmunol; 2019 Sep; 334():577005. PubMed ID: 31310926
[TBL] [Abstract][Full Text] [Related]
13. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
Li J; Gu Y; An H; Zhou Z; Zheng D; Wang Z; Wen Z; Shen HY; Wang Q; Wang H
Brain Behav; 2019 Aug; 9(8):e01354. PubMed ID: 31313506
[TBL] [Abstract][Full Text] [Related]
15. High Level of Soluble CD146 In Cerebrospinal Fluid Might be a Biomarker of Severity of Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Li Q; Chen J; Yin M; Zhao J; Lu F; Wang Z; Yu X; Wang S; Zheng D; Wang H
Front Immunol; 2021; 12():680424. PubMed ID: 34220828
[TBL] [Abstract][Full Text] [Related]
16. High serum creatinine is associated with reduction of psychiatric symptoms in female patients with anti-NMDAR encephalitis.
Wang N; Zeng Z; Wang B; Qin D; Wang T; Wang C; Guo S
Neurosci Lett; 2021 Feb; 746():135650. PubMed ID: 33485991
[TBL] [Abstract][Full Text] [Related]
17. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
Titulaer MJ; McCracken L; Gabilondo I; Armangué T; Glaser C; Iizuka T; Honig LS; Benseler SM; Kawachi I; Martinez-Hernandez E; Aguilar E; Gresa-Arribas N; Ryan-Florance N; Torrents A; Saiz A; Rosenfeld MR; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2013 Feb; 12(2):157-65. PubMed ID: 23290630
[TBL] [Abstract][Full Text] [Related]
18. Cell-Free Mitochondrial DNA in the CSF: A Potential Prognostic Biomarker of Anti-NMDAR Encephalitis.
Peng Y; Zheng D; Zhang X; Pan S; Ji T; Zhang J; Shen HY; Wang HH
Front Immunol; 2019; 10():103. PubMed ID: 30792710
[TBL] [Abstract][Full Text] [Related]
19. Status dystonicus in adult patients with anti-N-methyl-D-aspartate-acid receptor encephalitis.
Zhang Y; Cui L; Chen W; Huang H; Liu G; Su Y; Boltze J
J Neurol; 2023 May; 270(5):2693-2701. PubMed ID: 36810828
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of the NLRP3 inflammasome are associated with the severity of anti-NMDAR encephalitis in children.
Yang J; Li Y; Luo H; Ma J; Zheng Y; Zhou L; Ding R; Meng L; Zhang X; Jiang Y; Li X; Hong S; Jiang L
Clin Chim Acta; 2023 Nov; 551():117587. PubMed ID: 37813328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
